Drugs

High Tide Announces Addition to the Horizons Marijuana Life Sciences Index ETF (TSX: HMMJ) and Results of Annual General Meeting

Retrieved on: 
Friday, July 30, 2021

High Tide is a retail-focused cannabis company enhanced by the manufacturing and distribution of consumption accessories.

Key Points: 
  • High Tide is a retail-focused cannabis company enhanced by the manufacturing and distribution of consumption accessories.
  • The Company is the most profitable Canadian retailer of recreational cannabis as measured by Adjusted EBITDA1, with 88 current locations spanning Ontario, Alberta, Manitoba and Saskatchewan.
  • Key industry investors in High Tide include Tilray Inc. (TSX: TLRY) (Nasdaq: TLRY) and Aurora Cannabis Inc. (TSX: ACB) (Nasdaq: ACB).
  • For more information about High Tide Inc., please visit www.hightideinc.com and its profile page on SEDAR at www.sedar.com .

Bristol Myers Squibb Receives European Commission Approval for Opdivo (nivolumab) as Adjuvant Treatment for Esophageal or Gastroesophageal Junction Cancer Patients with Residual Pathologic Disease Following Chemoradiotherapy

Retrieved on: 
Friday, July 30, 2021

Bristol Myers Squibb (NYSE: BMY) today announced that the European Commission (EC) has approved Opdivo (nivolumab) for the adjuvant treatment of adult patients with esophageal or gastroesophageal junction (GEJ) cancer who have residual pathologic disease following prior neoadjuvant chemoradiotherapy (CRT).

Key Points: 
  • Bristol Myers Squibb (NYSE: BMY) today announced that the European Commission (EC) has approved Opdivo (nivolumab) for the adjuvant treatment of adult patients with esophageal or gastroesophageal junction (GEJ) cancer who have residual pathologic disease following prior neoadjuvant chemoradiotherapy (CRT).
  • Because as a leader in cancer care, Bristol Myers Squibb is working to empower all people with cancer to have a better future.
  • By harnessing the bodys own immune system to fight cancer, Opdivo has become an important treatment option across multiple cancers.
  • OPDIVO (nivolumab), in combination with cabozantinib, is indicated for the first-line treatment of patients with advanced renal cell carcinoma (RCC).

China's Infliximab Market Investigation Report 2021-2025 - ResearchAndMarkets.com

Retrieved on: 
Thursday, July 29, 2021

The "Investigation Report on China's Infliximab Market 2021-2025" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Investigation Report on China's Infliximab Market 2021-2025" report has been added to ResearchAndMarkets.com's offering.
  • By 2020, Janssen Biologics BV is the only manufacturer in the Chinese Infliximab market.
  • According to the market research, since Infliximab entered the Chinese market in 2007, its sales have had an increasing trend.
  • 2 Sales of Infliximab in China, 2016-2020
    2.3 Sales of Infliximab by Dosage Form in China, 2016-2020
    3 Analysis of Major Infliximab Manufacturers in China, 2016-2020
    4 Prices of Infliximab for Different Manufacturers in China, 2020-2021
    5 Prospect of Chinese Infliximab drug Market, 2021-2025
    View source version on businesswire.com: https://www.businesswire.com/news/home/20210729005802/en/

That’s it. Enters Keto Category with Keto Kick, a Clean, Plant-based Coffee Energy Bar

Retrieved on: 
Thursday, July 29, 2021

is giving the Keto industry the ultimate wake up call with todays launch of its innovative Keto Kick coffee energy bar.

Key Points: 
  • is giving the Keto industry the ultimate wake up call with todays launch of its innovative Keto Kick coffee energy bar.
  • Keto Kick is a groundbreaking new Keto energy bar made with only six real, whole ingredients, including 95mg of caffeine from Fair Trade, single-origin Ethiopian coffee beans.
  • With just six recognizable ingredients, including organic dates, garbanzo beans and coffee, this bar is clean, simple, and 100% plant-based.
  • Whether you follow a Keto diet or not, this mini bar makes a great alternative to your morning cup of coffee or usual afternoon pick-me-up.

Orbit Coffee Uses Maca Root To Keep Customers Focused

Retrieved on: 
Friday, July 30, 2021

Along with carefully formulated caffeine, coffee, and carbohydrates, the energy booster also utilizes the Peruvian wonder veggie Maca root to enhance its formula and make it more effective.

Key Points: 
  • Along with carefully formulated caffeine, coffee, and carbohydrates, the energy booster also utilizes the Peruvian wonder veggie Maca root to enhance its formula and make it more effective.
  • One of the biggest factors that helps Orbit Coffee stand out from the crowd, though, is its use of Maca root.
  • Along with adding an earthy, nutty flavor to the overall mixture, the Maca root present in Orbit Coffee can help boost performance, raise energy levels, improve mood, and enhance overall cognition.
  • About Orbit Coffee: Orbit Coffee is a product created by Cleverit Corp.

UPTRAVI® (selexipag) Receives FDA Approval for Intravenous Use in Adult Patients with Pulmonary Arterial Hypertension (PAH)

Retrieved on: 
Friday, July 30, 2021

For patients on UPTRAVI, bridging short-term temporary interruptions of UPTRAVI tablets with UPTRAVI IV may maintain the treatment effect and avoid the need to change therapy or re-titrate UPTRAVI tablets after re-initiation," said Kelly Chin, M.D.

Key Points: 
  • For patients on UPTRAVI, bridging short-term temporary interruptions of UPTRAVI tablets with UPTRAVI IV may maintain the treatment effect and avoid the need to change therapy or re-titrate UPTRAVI tablets after re-initiation," said Kelly Chin, M.D.
  • The UPTRAVI IV study enrolled 20 patients who received all UPTRAVI doses (either tablets or IV).
  • The study found that the switch between UPTRAVI tablets and UPTRAVI IV was well tolerated with no unexpected safety findings.
  • The study examined switching from a stable dose of UPTRAVI tablets to a corresponding dose of UPTRAVI IV and back to UPTRAVI tablets.

Braxia Scientific Provides Corporate Update and Reports Fiscal Fourth Quarter and Full-Year 2021 Financial Results

Retrieved on: 
Friday, July 30, 2021

Through its global leading researchers and experienced implementation team, Braxia Scientific has established its presence in the mental health industry.

Key Points: 
  • Through its global leading researchers and experienced implementation team, Braxia Scientific has established its presence in the mental health industry.
  • Braxia Health is the first to offer novel Ketamine therapy, including intravenous therapy, to patients in a private clinical setting in Quebec.
  • In June 2021, the Company announced that Chief Medical and Scientific Officer Dr. Joshua Rosenblat, will initiate a first-of-its-kind ketamine clinical trial to treat bipolar depression.
  • "Braxia Scientific has achieved significant milestones to date, and we are picking up the pace," noted CEO Dr. Roger McIntyre.

Insurance Companies Are Pushing Biosimilar Drugs That May Damage Vision

Retrieved on: 
Thursday, July 29, 2021

Even the drugs' manufacturers have advised against injecting the alternative drugs into the eye because there is no scientific proof to support it.

Key Points: 
  • Even the drugs' manufacturers have advised against injecting the alternative drugs into the eye because there is no scientific proof to support it.
  • This development has alarmed ophthalmologists because one of the drugs may be harmful to corneal tissue.
  • The newer biosimilar drugs have never been tested in the eye.
  • We are against the use of drugs in the eye that have never been tested for ophthalmic diseases.

Next Frontier Brands' Subsidiary TreeHouse Biosciences™ Announces the Launch of its THC Remediation Services Business Based on Patented Technology

Retrieved on: 
Thursday, July 29, 2021

This method utilizes chromatography, a process which separates chemical compounds based on their unique molecular properties.

Key Points: 
  • This method utilizes chromatography, a process which separates chemical compounds based on their unique molecular properties.
  • TreeHouse Biosciences also has filed a patent for the removal of THC from hemp extracts utilizing a mild combination of heat and oxygen.
  • Treehouse Biosciencesnow provides THC remediation services through its Boulder, Colorado operations, and intends to build remote modular processing units in selected states where hemp processing is prominent.
  • Treehouse Biosciencesis a leader in the research, development and production of hemp-derived cannabinoid ingredients,and purification and remediation technologies.

FDA Approves Expanded BOTOX® (onabotulinumtoxinA) Label to Include Eight New Muscles to Treat Adults with Upper Limb Spasticity

Retrieved on: 
Thursday, July 29, 2021

"This label expansion not only adds to our rich history in neurotoxin science, but also reinforces the role of BOTOX in upper limb spasticity treatment.

Key Points: 
  • "This label expansion not only adds to our rich history in neurotoxin science, but also reinforces the role of BOTOX in upper limb spasticity treatment.
  • Individuals with spasticity experience stiffness in the muscles of their upper and/or lower limbs, and may have difficulty with voluntary control.
  • The safety profile of BOTOX in adult upper limb spasticity remains the same, with the most common adverse reactions including nausea, fatigue, bronchitis, pain in extremity and muscular weakness.
  • In pediatric patients treated with BOTOX for upper limb spasticity, upper respiratory tract infections were reported more frequently.In pediatric patients treated with BOTOX for lower limb spasticity, upper respiratory tract infections were not reported more frequently than placebo.